Latest Breaking News On - Neurology section - Page 1 : comparemela.com

AbbVie Announces European Commission Approval of AQUIPTA® (atogepant) for the Preventive Treatment of Migraine in Adults

AbbVie (NYSE: ABBV) today announced that the European Commission has approved AQUIPTA® (atogepant) for the prophylaxis of migraine in adults who have four or more migraine days per month. The approval makes AQUIPTA the first and only once-daily oral calcitonin gene-related peptide (CGRP) receptor antagonist .

United statesRoopal thakkarInstitute of researchRegulatory affairsExchange commissionEuropean commissionEuropean unionBrain councilChief medical officerNeurology sectionHebron hospitalImportant safety informationAllergan aestheticsLooking statementsPrivate securities litigation reform actQuarterly reports

AbbVie Announces European Commission Approval of AQUIPTA® (atogepant) for the Preventive Treatment of Migraine in Adults

AbbVie Announces European Commission Approval of AQUIPTA® (atogepant) for the Preventive Treatment of Migraine in Adults
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesRoopal thakkarEuropean unionEuropean commissionExchange commissionEuropean brain councilInstitute of researchRegulatory affairsChief medical officerNeurology sectionHebron hospitalImportant safety informationAllergan aestheticsPrivate securities litigation reform actQuarterly reportsPain headache

AbbVie (ABBV) Announces EU Approval of AQUIPTA for Migraine in Adults

AbbVie (ABBV) Announces EU Approval of AQUIPTA for Migraine in Adults
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesPatricia pozo rosichRoopal thakkarEuropean commissionInstitute of researchEuropean unionRegulatory affairsChief medical officerNeurology sectionHebron hospital

AbbVie gains EU migraine treatment approval

AbbVie gains EU migraine treatment approval
europeanpharmaceuticalreview.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from europeanpharmaceuticalreview.com Daily Mail and Mail on Sunday newspapers.

Patricia pozo rosichRoopal thakkarEuropean commissionInstitute of researchRegulatory affairsNeurology sectionHebron hospitalSenior vice presidentChief medical officer

Bringing world-class neurosurgical procedures in PH

Bringing world-class neurosurgical procedures in PH
manilastandard.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from manilastandard.net Daily Mail and Mail on Sunday newspapers.

Pilar nenucap almiraGuillermo vt liabresGuillermo victorino liabresMichaeln sabalzaSaturnino javierSales services arlynl songcoStroke teamMakati medical center makatimedNational library of medicineWorld stroke organizationDepartment of neurosciences neurology sectionMakatimed neurosurgery departmentSenior vice presidentSales services arlynPilar nenucaMakatimed medical director saturnino